Creating Higher Titer Lentivirus with Caffeine

被引:44
作者
Ellis, Brian L. [1 ]
Potts, Patrick Ryan [1 ]
Porteus, Matthew H. [1 ,2 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA
[2] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA
关键词
SEVERE COMBINED IMMUNODEFICIENCY; CHRONIC GRANULOMATOUS-DISEASE; CELL GENE-THERAPY; DEPENDENT PROTEIN-KINASE; RADIOSENSITIZING AGENT; VECTOR INTEGRATION; SODIUM-BUTYRATE; IN-VIVO; DNA-PK; VIRUS;
D O I
10.1089/hum.2010.068
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The use of lentiviral vectors extends from the laboratory, where they are used for basic studies in virology and as gene transfer vectors gene delivery, to the clinic, where clinical trials using these vectors for gene therapy are currently underway. Lentiviral vectors are useful for gene transfer because they have a large cloning capacity and a broad tropism. Although procedures for lentiviral vector production have been standardized, simple methods to create higher titer virus during production would have extensive and important applications for both research and clinical use. Here we present a simple and inexpensive method to increase the titer by 3- to 8-fold for both integration-competent lentivirus and integration-deficient lentivirus. This is achieved during standard lentiviral production by the addition of caffeine to a final concentration of 2-4 mM. We find that sodium butyrate, a histone deacetylase inhibitor shown previously to increase viral titer, works only similar to 50% as well as caffeine. We also show that the DNA-PKcs (DNA-dependent protein kinase catalytic subunit) inhibitor NU7026 can also increase viral titer, but that the combination of caffeine and NU7026 is not more effective than caffeine alone. We show that the time course of caffeine treatment is important in achieving a higher titer virus, and is most effective when caffeine is present from 17 to 41 hr posttransfection. Last, although caffeine increases lentiviral vector titer, it has the opposite effect on the titer of adeno-associated virus type 2 vector. Together, these results provide a novel, simple, and inexpensive way to significantly increase the titer of lentiviral vectors.
引用
收藏
页码:93 / 100
页数:8
相关论文
共 32 条
[1]   Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning [J].
Aiuti, A ;
Slavin, S ;
Aker, M ;
Ficara, F ;
Deola, S ;
Mortellaro, A ;
Morecki, S ;
Andolfi, G ;
Tabucchi, A ;
Carlucci, F ;
Marinello, E ;
Cattaneo, F ;
Vai, S ;
Servida, P ;
Miniero, R ;
Roncarolo, MG ;
Bordignon, C .
SCIENCE, 2002, 296 (5577) :2410-2413
[2]   DNA damage sensors ATM, ATR, DNA-PKcs, and PARP-1 are dispensable for human immunodeficiency virus type 1 integration [J].
Ariumi, Y ;
Turelli, P ;
Masutani, M ;
Trono, D .
JOURNAL OF VIROLOGY, 2005, 79 (05) :2973-2978
[3]   Integrase-defective lentiviral vectors: progress and applications [J].
Banasik, M. B. ;
McCray, P. B., Jr. .
GENE THERAPY, 2010, 17 (02) :150-157
[4]   Selective inhibition of the DNA-dependent protein kinase (DNA-PK) by the radiosensitizing agent caffeine [J].
Block, WD ;
Merkle, D ;
Meek, K ;
Lees-Miller, SP .
NUCLEIC ACIDS RESEARCH, 2004, 32 (06) :1967-1972
[5]   Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy [J].
Cartier, Nathalie ;
Hacein-Bey-Abina, Salima ;
Bartholomae, Cynthia C. ;
Veres, Gabor ;
Schmidt, Manfred ;
Kutschera, Ina ;
Vidaud, Michel ;
Abel, Ulrich ;
Dal-Cortivo, Liliane ;
Caccavelli, Laure ;
Mahlaoui, Nizar ;
Kiermer, Veronique ;
Mittelstaedt, Denice ;
Bellesme, Celine ;
Lahlou, Najiba ;
Lefrere, Francois ;
Blanche, Stephane ;
Audit, Muriel ;
Payen, Emmanuel ;
Leboulch, Philippe ;
l'Homme, Bruno ;
Bougneres, Pierre ;
Von Kalle, Christof ;
Fischer, Alain ;
Cavazzana-Calvo, Marina ;
Aubourg, Patrick .
SCIENCE, 2009, 326 (5954) :818-823
[6]   Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease [J].
Cavazzana-Calvo, M ;
Hacein-Bey, S ;
Basile, CD ;
Gross, F ;
Yvon, E ;
Nusbaum, P ;
Selz, F ;
Hue, C ;
Certain, S ;
Casanova, JL ;
Bousso, P ;
Le Deist, F ;
Fischer, A .
SCIENCE, 2000, 288 (5466) :669-672
[7]   APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons [J].
Chen, H ;
Lilley, CE ;
Yu, Q ;
Lee, DV ;
Chou, J ;
Narvaiza, I ;
Landau, NR ;
Weitzman, MD .
CURRENT BIOLOGY, 2006, 16 (05) :480-485
[8]   Gene therapy improves immune function in preadolescents with X-linked severe combined immunodeficiency [J].
Chinen, Javier ;
Davis, Joie ;
De Ravin, Suk See ;
Hay, Beverly N. ;
Hsu, Amy P. ;
Linton, Gilda F. ;
Naumann, Nora ;
Nomicos, Effie Y. H. ;
Silvin, Christopher ;
Ulrick, Jean ;
Whiting-Theobald, Narda L. ;
Malech, Harry L. ;
Puck, Jennifer M. .
BLOOD, 2007, 110 (01) :67-73
[9]   IDENTIFICATION OF CONSERVED AMINO-ACID-RESIDUES CRITICAL FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE FUNCTION-INVITRO [J].
ENGELMAN, A ;
CRAIGIE, R .
JOURNAL OF VIROLOGY, 1992, 66 (11) :6361-6369
[10]   Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning [J].
Gaspar, H. Bobby ;
Bjorkegren, Emma ;
Parsley, Kate ;
Gilmour, Kimberly C. ;
King, Doug ;
Sinclair, Joanna ;
Zhang, Fang ;
Giannakopoulos, Aris ;
Adams, Stuart ;
Fairbanks, Lynette D. ;
Gaspar, Jane ;
Henderson, Lesley ;
Xu-Bayford, Jin Hua ;
Davies, E. Graham ;
Veys, Paul A. ;
Kinnon, Christine ;
Thrasher, Adrian J. .
MOLECULAR THERAPY, 2006, 14 (04) :505-513